AzTrials
AzTrials

Communication DisabilitiesDECANCT07656584

Implementation of Communication Disability Collection and Accommodations in Primary Care Settings

A study testing Implementation Support Package in people with Communication Disabilities, run by NYU Langone Health at 5 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This multi-methods-multi-site study aims to adapt and evaluate the effects of an implementation support package of strategies to assist primary care clinics in documenting patients' communication disability (CD) and accommodation needs in the electronic health record (EHR) and providing communication accommodations… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Communication Disabilities
What is being tested?
Implementation Support Package
Could I receive a placebo?
No, everyone receives an active treatment
How many people
126,870 participants
Where
5 sitesUnited States
Study dates
1 Sep 2025to 31 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • EHR Data Extraction
  • Adults 18+ years
  • Patients who had at least one visit within the 21-month EHR data collection period at participating study clinics.
  • Clinic Leadership, Providers \& Clinic Staff
  • Adults 18+ years
  • Individuals of all genders and members of all racial and ethnic categories employed at participating study clinics will be eligible for inclusion. NYULH study personnel will enroll providers and staff referred for study inclusion from all participating study clinics; not just NYULH staff exclusively.
Show all 10Show fewer
  • Patients
  • Adults 18+ years
  • Patients with communication disabilities seen at least once at participating study clinics during the 21-month study period.
  • Patients who self-identify as proficient in English communication as defined by English being a preferred language, or self-reported ability to participate in an interview in English without the support of an interpreter.

Who cannot join

  • EHR Data Extraction
  • Patients whose records are unavailable due to technical issues.
  • Patients who are not seen at least once at participating study clinics during the 21-month data collection period.
  • Duplicate records (e.g., duplicative EHR records marked for deletion).
  • Patients who have opted-out of research participation.
  • Clinic Leadership, Providers \& Clinic Staff Interviews and Focus Groups
Show all 14Show fewer
  • Being <18 years old
  • Not an employed member of a participating study clinic or potential end user of the study implementation strategy.
  • Patient Interviews
  • Being <18 years old
  • Patients without communication disabilities.
  • Patients with communication disabilities seen outside of participating study clinics.
  • Patients who are unable to provide consent for themselves.
  • Patients who report not being proficient in English communication or self-reported inability to participate in an interview in English without the support of an interpreter.

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

5 sites in 1 country

United States5 sites, 5 recruiting
  • The University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045

    Christina Studts, PhD

    Recruiting
  • University of Illinois Chicago

    Chicago, Illinois, 60612

    Jennifer Duffecy, MD

    Recruiting
  • Denver Health

    Denver, Colorado, 80204

    Alicia Wong, MD

    Recruiting
  • Northwestern University

    Evanston, Illinois, 60611

    Carol Haywood, PhD

    Recruiting
  • NYU Langone Health

    New York, New York, 10016

    Meghan Morris, PhD

    Recruiting

Other trials in United States

About this study

This multi-methods-multi-site study aims to adapt and evaluate the effects of an implementation support package of strategies to assist primary care clinics in documenting patients' communication disability (CD) and accommodation needs in the electronic health record (EHR) and providing communication accommodations through EHR data extraction, surveys, focus groups, interviews, and clinical practice observations.

Being tested
Implementation Support Package
Medical subject headings
Communication Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Implementation Support PackageBehavioural

    The implementation support package includes materials, activities, and procedures ready for use in diverse primary care practices and will facilitate each clinic's determination of how they will implement collection of disability status and provision of accommodations.

Study groups in NCT07656584
Study groupRoleWhat they receive
Implementation Support Package ClinicsExperimentalClinics will receive an implementation support package, designed to integrate patients' disability status into the EHR and provide accommodations for patients with CD
Receives: Behavioral: Implementation Support Package
Control ClinicsNo interventionClinics will not receive the implementation support package for patients with CD.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. (Aim 2) Patient Reach

    Percent of patients who have a visit during the time of data collection and have the communication disability field completed in the EHR. A positive outcome for having the communication disability field completed in the EHR will be "no disability" "speech/language disability", "hearing disability", "decline", or "other" documented in the EHR, while a negative outcome will be the CD fields being left blank. All adult patients who are seen in each clinic are eligible to have their disability status documented, regardless of the type of visit.

    Measured: Baseline, Implementation Follow Up (Approximately Month 9), Maintenance Follow Up (Approximately Month 21)

  2. (Aim 3) Adoption

    Adoption assessed for all the patients with a recorded accommodation need; measured as the percentage of clinical encounters in which the accommodation was provided and used, as ascertained through the EHR.

    Measured: Implementation Follow Up (Approximately Month 9), Maintenance Follow Up (Approximately Month 21)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jun 2026
  2. Study start1 Sep 2025
  3. Primary completion30 Mar 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
126,870 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07656584
Sponsor's protocol ID
25-00040
Acronym
DECA
Status last verified
Jul 2026
First submitted
15 Jun 2026
Last updated
8 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The de-identified participant data from the final research dataset will be deposited to the digital repository of the Inter-university Consortium for Political and Social Research (ICPSR) to ensure that the research community has long-term access to the data. These files may be accessed directly through the ICPSR website. After agreeing to Terms of Use, users with an ICPSR My Data account and an authorized IP address from a member institution may download the data, and non-members may purchase the files. The research data from this project will be supplied to ICPSR for permanent storage at the end of the project and incrementally; all data not otherwise published by the end of the grant period will be embargoed for one year to allow finalizations of manuscripts and data preparation for sharing. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Questions about this trial

What is this clinical trial studying?

A study testing Implementation Support Package in people with Communication Disabilities, run by NYU Langone Health at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Megan Morris, PhD (646-501-0027, megan.morris@nyulangone.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

(Aim 2) Patient Reach (time frame: Baseline, Implementation Follow Up (Approximately Month 9), Maintenance Follow Up (Approximately Month 21)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in